Literature DB >> 6761656

Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.

C M Ginsburg, G H McCracken, J B Steinberg, S D Crow, B F Dildy, K Lancaster, K Olsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6761656

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN： 0277-9730


× No keyword cloud information.
  4 in total

1.  Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.

Authors:  D Adam; H Scholz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

2.  Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.

Authors:  D Bérubé; D Kirouac; D Croteau; M G Bergeron; M Lebel
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group.

Authors:  H Scholz; R Noack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

4.  Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.

Authors:  D Croteau; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.